Giuseppi Auteri

8PUBLICATIONS
45CO-AUTHORS
Social program evaluationRegenerative medicine (incl. stem cells)Respiratory diseasesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
Vitamin K Antagonist Treatment Burden Assessed with the Patient Reported Outcome "Anti Clot Treatment Scale": KAFe Trial, a Single-Center Study Involving 202 Patients.

|Mar 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib.

Andrew T Kuykendall, Somedeb Ball, Barbara Mora

|Jul 29, 2023
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.

Francesca Palandri, Elena Rossi, Giuseppe Auteri

|Apr 01, 2022
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.

Francesca Palandri, Daniela Bartoletti, Alessandra Iurlo

|Dec 23, 2021
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies.

Francesca Palandri, Christian Di Pietro, Francesca Ricci

|Apr 23, 2021
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.

Francesca Palandri, Elena Rossi, Daniela Bartoletti

Pageof 2

Frequent Collaborators

7 joint publications

Francesca Palandri

4 joint publications

Daniela Bartoletti

3 joint publications

Giulia Benevolo

3 joint publications

Massimo Breccia